000 01564 a2200469 4500
005 20250517141908.0
264 0 _c20180131
008 201801s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-017-00152-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCounsell, John R
245 0 0 _aLentiviral vectors can be used for full-length dystrophin gene therapy.
_h[electronic resource]
260 _bScientific reports
_c03 2017
300 _a79 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCells, Cultured
650 0 4 _aDNA Packaging
650 0 4 _aDystrophin
_xgenetics
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
_xgenetics
650 0 4 _aHEK293 Cells
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aLentivirus
_xgenetics
650 0 4 _aMuscular Dystrophy, Duchenne
_xgenetics
650 0 4 _aMyoblasts, Skeletal
_xmetabolism
650 0 4 _aRecombination, Genetic
650 0 4 _aTransduction, Genetic
700 1 _aAsgarian, Zeinab
700 1 _aMeng, Jinhong
700 1 _aFerrer, Veronica
700 1 _aVink, Conrad A
700 1 _aHowe, Steven J
700 1 _aWaddington, Simon N
700 1 _aThrasher, Adrian J
700 1 _aMuntoni, Francesco
700 1 _aMorgan, Jennifer E
700 1 _aDanos, Olivier
773 0 _tScientific reports
_gvol. 7
_gno. 1
_gp. 79
856 4 0 _uhttps://doi.org/10.1038/s41598-017-00152-5
_zAvailable from publisher's website
999 _c26926544
_d26926544